Examples
|
| Enablex | darifenacin hydrobromide | |
| Toviaz | fesoterodine | |
| Ditropan, Ditropan XL, Oxytrol | oxybutynin chloride | |
| Vesicare | solifenacin succinate | |
| Detrol, Detrol LA | tolterodine tartrate | |
| Sanctura, Sanctura XR | trospium chloride | |
How It Works
These medicines calm the nerves that
control bladder muscles. They may prevent uncontrollable bladder contractions
that force urine out of the bladder.
Why It Is Used
Antispasmodics and anticholinergics
are used to control the symptoms of
urge incontinence. These medicines may also be used to treat
stress incontinence, especially if you have both
stress and urge incontinence.
How Well It Works
These medicines can help men control
urge incontinence. Typically, men who take these medicines can hold their urine
for a longer time. And when they do have the urge to urinate, it is not as
strong as it is without medicine.1
Side Effects
Side effects vary with some of these
medicines and include:
- Dry
mouth.
- Headache.
- Decreased sweating, skin
rash.
- Nausea, constipation.
- Eye
problems.
- Rapid heartbeat.
- Skin
rash.
- Drowsiness,
confusion.
- Nervousness.
- Urinary retention.
See Drug Reference for a full list of side effects. (Drug
Reference is not available in all systems.)
What To Think About
If you have the eye disease
glaucoma, it is important for you to talk with your
ophthalmologist before you start taking
anticholinergics. People who have glaucoma may need to be watched more closely
while they are taking anticholinergic medicines.
Some of these
medicines may cause you to sweat less. In hot weather, this could lead to
heat exhaustion. Ask your doctor whether you should be
careful about being physically active in hot conditions.
Complete the new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
Nitti VW, Blaivas JG (2007). Urinary incontinence:
Epidemiology, pathophysiology, evaluation, and management overview. In AJ Wein
et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3,
pp. 2046-2078. Philadelphia: Saunders Elsevier.
Credits
| Author | Monica Rhodes |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Specialist Medical Reviewer | Avery L. Seifert, MD - Urology |
| Last Updated | July 21, 2008 |
Nitti VW, Blaivas JG (2007). Urinary incontinence:
Epidemiology, pathophysiology, evaluation, and management overview. In AJ Wein
et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3,
pp. 2046-2078. Philadelphia: Saunders Elsevier.